Trial intelligence / Profile preview

Amantadine for recovery after severe traumatic brain injury

2008-001694-15Phase 3Completed

Sponsor
Afdeling for Traumatisk Hjerneskade
Start
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) and disorder of consciousness (DOC) comparing Amantadine with Placebo (2 arms). Primary endpoint: Disability Rating Scale (DRS). Started Apr 2008; status: completed.

02

Drugs

amantadine
03

Conditions

traumatic brain injury (TBI)disorder of consciousness (DOC)

Beyond the preview

Go deeper on 2008-001694-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001694-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call